Form D/A - Notice of Exempt Offering of Securities: [Amend]
SEC Accession No. 0001140361-14-014775
Filing Date
2014-03-31
Accepted
2014-03-31 15:06:15
Documents
1
Effectiveness Date
2014-03-31
Items
Item 06b:

Document Format Files

Seq Description Document Type Size
1 primary_doc.html D/A  
1 primary_doc.xml D/A 9564
  Complete submission text file 0001140361-14-014775.txt   10627
Mailing Address 43 THORNDIKE STREET SUITE S1-3 CAMBRIDGE MA 02141
Business Address 43 THORNDIKE STREET SUITE S1-3 CAMBRIDGE MA 02141 617-758-0300
Neurovance, Inc. (Filer) CIK: 0001544176 (see all company filings)

EIN.: 454090332 | State of Incorp.: DE | Fiscal Year End: 1231
Type: D/A | Act: 33 | File No.: 021-185561 | Film No.: 14729609